Home

scrapbook conservative Melodic nccn ipi Smooth scrub reputation

The prognostic value of IPI in patients with primary breast lymphoma, a  multicenter retrospective study | Cancer Cell International | Full Text
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study | Cancer Cell International | Full Text

Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 4 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

KoreaMed Synapse
KoreaMed Synapse

Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and  NCCN‑IPI in patients with diffuse large B‑cell lymphoma
Interim 18F‑FDG PET/CT improves the prognostic value of S‑IPI, R‑IPI and NCCN‑IPI in patients with diffuse large B‑cell lymphoma

Videomed
Videomed

Validation of the International Prognostic Index and Subsequent Revisions  for Diffuse Large B-Cell Lymphoma in Patients From the
Validation of the International Prognostic Index and Subsequent Revisions for Diffuse Large B-Cell Lymphoma in Patients From the

Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of  Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma  Group Study | JCO Clinical Cancer Informatics
Optimizing Outcome Prediction in Diffuse Large B-Cell Lymphoma by Use of Machine Learning and Nationwide Lymphoma Registries: A Nordic Lymphoma Group Study | JCO Clinical Cancer Informatics

Prognostic indices and the risk stratification of IPI and NCCN-IPI. |  Download Table
Prognostic indices and the risk stratification of IPI and NCCN-IPI. | Download Table

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

Frontiers | Risk Stratification for Diffuse Large B-Cell Lymphoma by  Integrating Interim Evaluation and International Prognostic Index: A  Multicenter Retrospective Study
Frontiers | Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

The Enhanced International Prognostic Index for Diffuse Large B‐cell  Lymphoma | Semantic Scholar
The Enhanced International Prognostic Index for Diffuse Large B‐cell Lymphoma | Semantic Scholar

Validation of an enhanced International Prognostic Index (NCCN-IPI) in an  Asian cohort of patients with diffuse large B cell lymphoma | SpringerLink
Validation of an enhanced International Prognostic Index (NCCN-IPI) in an Asian cohort of patients with diffuse large B cell lymphoma | SpringerLink

Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to  Management?
Diffuse Large B-Cell Lymphoma: Can We Improve Our Current Approaches to Management?

Immunohistochemical double hit score enhances NCCN–IPI and is associated  with detrimental outcomes in refractory or relapsing patients with diffuse  large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -
Immunohistochemical double hit score enhances NCCN–IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma - Prochazka - 2018 - British Journal of Haematology -

xmlinkhub
xmlinkhub

Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for  patients with diffuse large B-cell lymphoma treated in the rituximab era. |  Semantic Scholar
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar

CT-Based Versus FDG-PET/CT–Based NCCN International Prognostic Index Risk  Stratification in DLBCL in: Journal of the National Comprehensive Cancer  Network Volume 13 Issue 2 (2015)
CT-Based Versus FDG-PET/CT–Based NCCN International Prognostic Index Risk Stratification in DLBCL in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 2 (2015)

We applied the model of (A) NCCN-IPI in our study. Compared with (B)... |  Download Scientific Diagram
We applied the model of (A) NCCN-IPI in our study. Compared with (B)... | Download Scientific Diagram

Age cutoffs for the conventional IPI, NCCN-IPI, and GELTAMO-IPI | Download  Scientific Diagram
Age cutoffs for the conventional IPI, NCCN-IPI, and GELTAMO-IPI | Download Scientific Diagram

NCCN-IPI score-independent prognostic potential of pretreatment uric acid  levels for clinical outcome of diffuse large B-cell lymphoma patients |  British Journal of Cancer
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients | British Journal of Cancer

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... |  Download Table
Comparison of classic IPI, NCCN-IPI, and modified prognostic model for... | Download Table